Amrutanjan Health Care
NSE: AMRUTANJAN · ISIN INE098F01031 · Healthcare
₹515.00−2.80 (−0.54%)
Monday 9 November, 12:04 IST. Delayed. Source: Yahoo Finance.
Price chart
₹515.00 −2.80 (−0.54%) today
The day
- Previous close
- ₹517.80
- Open
- ₹513.10
- Day high
- ₹520.50
- Day low
- ₹499.80
Listed on NSE since 2 January 2015.
Key numbers
- Market value
- ₹1,486.76 Cr
- P/E (trailing)
- 27.55
- EPS (trailing)
- ₹18.67
- Price to book
- 4.02
- Dividend yield
- 0.98%
- Debt to equity
- 0.00
- Profit margin
- 10.6%
- Beta
- 0.42
- Volume today
- 39,800
- Average volume
- 82,938
Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.
Revenue and profit
| Year | Revenue | Net profit |
|---|---|---|
| FY23 | ₹378.23 Cr | ₹39.83 Cr |
| FY24 | ₹420.12 Cr | ₹44.97 Cr |
| FY25 | ₹450.51 Cr | ₹50.83 Cr |
| FY26 | ₹501.68 Cr | ₹57.92 Cr |
Source: Yahoo Finance, from annual reports. Consolidated where reported.
Quarterly results
| Quarter | Revenue | Net profit | Profit vs year ago |
|---|---|---|---|
| Q2 FY27Jul–Sep 2026 | ₹135 Cr | ₹17 Cr | +23.8% |
| Q1 FY27Apr–Jun 2026 | ₹103 Cr | ₹4 Cr | −47.5% |
| Q4 FY26Jan–Mar 2026Audited | ₹150 Cr | ₹16 Cr | +6.7% |
| Q3 FY26Oct–Dec 2025 | ₹141 Cr | ₹19 Cr | – |
| Q2 FY26Jul–Sep 2025 | ₹118 Cr | ₹14 Cr | – |
| Q1 FY26Apr–Jun 2025 | ₹94 Cr | ₹8 Cr | – |
Source: Amrutanjan Health Care’s results filed with NSE, standalone (the company alone). Net profit is the share of Amrutanjan Health Care’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.
Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.
Balance sheet
| As on | September 2026 | March 2026 |
|---|---|---|
| Fixed assets | ₹189 Cr | ₹155 Cr |
| Investments | ₹3 Cr | ₹3 Cr |
| Inventories | ₹58 Cr | ₹37 Cr |
| Owed by customers | ₹44 Cr | ₹61 Cr |
| Cash and equivalents | ₹8 Cr | ₹11 Cr |
| Total assets | ₹515 Cr | ₹509 Cr |
| Borrowings | ₹0 | ₹0 |
| Total liabilities | ₹131 Cr | ₹139 Cr |
| Shareholders’ equity | ₹384 Cr | ₹370 Cr |
Source: Amrutanjan Health Care’s half-yearly statements of assets and liabilities filed with NSE, standalone. Companies file these every September and March.
About Amrutanjan Health Care
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene & Personal Care, and Others segments. The company provides pain management products comprising pain balms and roll-ons, back pain roll-ons, stick-on patch, and joint muscle sprays; dental pain gel; and decorn corn caps; hand sanitizer under the NOGerms brand name; and enerlyte and electro, and fruit and rehydration juice drinks under the Fruitnik brand name. The company also offers congestion management products that consists of cold rubs, cough syrups, nasal inhalers, and swas mints, as well as provides sanitary napkins for women. In addition, it operates a pain management center. The company was formerly known as Amrutanjan Limited and changed its name to Amrutanjan Health Care Limited in 2007. Amrutanjan Health Care Limited was founded in 1893 and is based in Chennai, India.
- Industry
- Drug Manufacturers - Specialty & Generic
- Based in
- Chennai
- Employees
- 661
Company website · Profile: Yahoo Finance
In the news
All newsNo headlines name Amrutanjan Health Care in the last day or two.
Dividends and corporate actions
All companies- Interim Dividend - Re 1 Per Share
Dividend · ex-date 6 November 2026 · record date 7 November 2026
- Dividend - Rs 2.90 Per Share
Dividend · ex-date 11 September 2026
- Interim Dividend - Re 1 Per Share
Dividend · ex-date 6 February 2026 · record date 7 February 2026
- Interim Dividend - Re 1 Per Share
Dividend · ex-date 18 November 2025
- Dividend - Rs 2.60 Per Share
Dividend · ex-date 16 September 2025
- Interim Dividend - Re 1 Per Share
Dividend · ex-date 18 February 2025
- Interim Dividend - Re 1 Per Share
Dividend · ex-date 22 November 2024
- Annual General Meeting
Action · ex-date 13 September 2024
Source: NSE. Latest first, 8 of 20.
Information only, not investment advice. Prices are delayed.